Genuv
CompanySouth Korea
Genuv develops one asset, in phase 1, discontinued (SNR1611 in amyotrophic lateral sclerosis). Based in South Korea.
- 1
- Asset
- Furthest stage
- Phase 1, discontinued
- 1
- Trial
- 0
- Signals
Pipeline
1Phase 1, discontinued, amyotrophic lateral sclerosis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Similar companies6